Enzymes Practice Questions

Q: The type of enzyme inhibition observed when xanthine oxidase is inhibited by allopurinol is an example of:

Suicidal. **Explanation:** **Suicide Inhibition (Mechanism-Based Inhibition)** occurs when an enzyme converts a substrate analogue into a highly reactive intermediate that binds irreversibly to the enzyme's active site, permanently inactivating it. In the case of **Allopurinol**, the enzyme **Xanthine Oxidase** initially treats it as a substrate and converts it into **Alloxanthine (Oxypurinol)**. Alloxanthine then binds tightly to the molybdenum-sulfide complex at the active site of xanthine oxidase, effectively "killing" the enzyme it helped create. This is a classic example of "suicide" because the enzyme participates in its own destruction. **Why other options are incorrect:** * **Noncompetitive:** The inhibitor binds to a site other than the active site (E or ES complex). It decreases $V_{max}$ but $K_m$ remains unchanged. * **Uncompetitive:** The inhibitor binds only to the Enzyme-Substrate (ES) complex. Both $V_{max}$ and $K_m$ decrease. * **Allosteric:** These enzymes have a "regulatory site" distinct from the active site. Binding of an effector causes a conformational change, often following sigmoidal kinetics rather than Michaelis-Menten kinetics. **NEET-PG High-Yield Pearls:** * **Other Suicide Inhibitors:** Aspirin (Cyclooxygenase), 5-Fluorouracil (Thymidylate synthase), Penicillin (Transpeptidase), and Disulfiram (Aldehyde dehydrogenase). * **Clinical Use:** Allopurinol is the drug of choice for **Chronic Gout** as it lowers serum uric acid levels. * **Key Distinction:** Unlike standard competitive inhibition, suicide inhibition is **irreversible**.

Q: Enzyme levels in tissue injury are due to which of the following mechanisms?

Lysis of cells. ### Explanation **1. Why "Lysis of cells" is correct:** In a healthy state, most metabolic enzymes are intracellular, maintained within the cytoplasm or organelles by the semi-permeable cell membrane. When tissue injury occurs—whether due to hypoxia, toxins, or mechanical trauma—the integrity of the cell membrane is compromised. This leads to **cell lysis** or increased membrane permeability, allowing intracellular enzymes to leak into the interstitial fluid and subsequently into the bloodstream. Therefore, an elevation of these enzymes in the serum serves as a diagnostic marker for specific organ damage. **2. Why the other options are incorrect:** * **Enzyme secretion:** This is a physiological process (e.g., pancreatic exocrine secretion of digestive enzymes into the gut). While some secreted enzymes are found in blood, a sudden pathological rise in serum levels is typically due to leakage from damage, not an increase in the active secretion process. * **Absence of inhibitors in serum:** Serum actually contains many inhibitors (e.g., $\alpha_1$-antitrypsin) to neutralize proteases. However, the *rise* in enzyme levels post-injury is due to the increased "source" (the damaged cell), not a sudden disappearance of baseline inhibitors. **3. Clinical Pearls for NEET-PG:** * **Rate of Release:** Small, cytoplasmic enzymes (e.g., LDH, CK) appear in the blood faster than large or membrane-bound enzymes. * **Organ Specificity:** * **ALT (Alanine Transaminase):** More specific for liver injury than AST. * **CK-MB:** Marker for Myocardial Infarction (rises within 4–6 hours). * **Lipase:** More specific for Acute Pancreatitis than Amylase. * **Key Concept:** Serum enzyme activity depends on the rate of release from damaged cells versus the rate of clearance from the circulation.

Q: What is true about Glutathione reductase?

It is a free radical scavenger.. **Explanation:** **Glutathione Reductase (GR)** is a critical antioxidant enzyme that maintains the pool of reduced glutathione (GSH) in the cell. Its primary role is to catalyze the reduction of glutathione disulfide (GSSG) back to reduced glutathione (GSH) using **NADPH** as a reducing equivalent. **Why Option C is Correct:** Reduced glutathione (GSH) acts as a potent **free radical scavenger**. It neutralizes reactive oxygen species (ROS) like hydrogen peroxide ($H_2O_2$) via the enzyme Glutathione Peroxidase. Since Glutathione Reductase is essential for regenerating GSH from its oxidized form, it is fundamentally classified as a key component of the cellular antioxidant defense system and a free radical scavenger. **Analysis of Incorrect Options:** * **Option A:** While glutathione itself is a tripeptide containing sulfur (cysteine), Glutathione Reductase is a **flavoprotein** containing **FAD** (Flavin Adenine Dinucleotide) as a cofactor, not primarily characterized as a "sulfur-containing enzyme." * **Option B:** Methemoglobinemia is primarily managed by **NADH-cytochrome b5 reductase** (Diaphorase I). While the HMP shunt provides NADPH for RBC integrity, the specific enzyme linked to preventing methemoglobin is not Glutathione Reductase. **High-Yield Clinical Pearls for NEET-PG:** * **Source of NADPH:** The NADPH required by Glutathione Reductase is supplied by the **HMP Shunt** (Pentose Phosphate Pathway) via the enzyme **G6PD**. * **RBC Hemolysis:** In G6PD deficiency, a lack of NADPH leads to a failure of Glutathione Reductase. This results in accumulated $H_2O_2$, causing hemoglobin denaturation and the formation of **Heinz bodies** and **Bite cells**. * **Riboflavin Connection:** Since GR requires FAD, its activity is used as a functional assay to bridge a diagnosis of **Vitamin B2 (Riboflavin) deficiency**.

Q: Sulfite oxidase is the last enzyme in the pathway for degradation of sulfur-containing amino acids. What is the cofactor for sulfite oxidase?

Molybdenum. **Explanation:** **Sulfite oxidase** is a mitochondrial enzyme that catalyzes the final step in the degradation of sulfur-containing amino acids (Cysteine and Methionine). It converts toxic **sulfite ($SO_3^{2-}$)** into non-toxic **sulfate ($SO_4^{2-}$)**. 1. **Why Molybdenum is Correct:** Sulfite oxidase requires **Molybdenum (Mo)** as an essential cofactor. Specifically, the molybdenum is held within a complex organic molecule called **Molybdopterin**. This "Molybdenum cofactor" (MoCo) is also required by two other key enzymes: Xanthine oxidase (purine metabolism) and Aldehyde oxidase. 2. **Why Other Options are Incorrect:** * **Copper (Cu):** A cofactor for enzymes like Cytochrome c oxidase, Tyrosinase, and Lysyl oxidase. * **Zinc (Zn):** A cofactor for Carbonic anhydrase, Alcohol dehydrogenase, and Carboxypeptidase. * **Iron (Fe):** Found in Heme-containing enzymes (Catalase, Cytochromes) and Non-heme enzymes (Aconitase). 3. **Clinical Pearls (High-Yield for NEET-PG):** * **Molybdenum Cofactor Deficiency (MoCD):** A rare autosomal recessive disorder. Since sulfite oxidase cannot function, sulfites accumulate, leading to severe neurological damage, seizures, and **ectopia lentis** (dislocation of the lens). * **Biochemical Marker:** Patients with MoCD or Sulfite Oxidase deficiency will show **low plasma sulfate** and **high urinary sulfite** levels. * **Xanthine Connection:** Because Molybdenum is shared with Xanthine oxidase, MoCD also results in **hypouricemia** (low serum uric acid) and increased xanthine excretion.

Q: Which organelle is primarily responsible for the catabolism of hydrogen peroxide (H2O2)?

Peroxisomes. **Explanation:** **1. Why Peroxisomes are correct:** Peroxisomes (also known as microbodies) are membrane-bound organelles specialized for oxidative reactions. They contain high concentrations of **Catalase**, the primary enzyme responsible for the catabolism of hydrogen peroxide ($H_2O_2$) into water and oxygen ($2H_2O_2 \rightarrow 2H_2O + O_2$). This process is vital for protecting the cell from oxidative damage caused by reactive oxygen species (ROS) generated during the $\beta$-oxidation of very-long-chain fatty acids (VLCFA). **2. Why other options are incorrect:** * **Mitochondria:** While mitochondria produce $H_2O_2$ as a byproduct of the electron transport chain and contain Glutathione peroxidase, their primary role is ATP production via oxidative phosphorylation, not the specialized catabolism of $H_2O_2$. * **Endoplasmic Reticulum (ER):** The ER is primarily involved in protein synthesis (RER), lipid synthesis, and detoxification via the Cytochrome P450 system (SER), but it lacks the high catalase activity characteristic of peroxisomes. * **Lysosomes:** These are the "suicide bags" of the cell, containing acid hydrolases for the degradation of macromolecules (proteins, lipids, polysaccharides) at an acidic pH. They do not play a role in peroxide metabolism. **3. High-Yield Clinical Pearls for NEET-PG:** * **Zellweger Syndrome:** A rare autosomal recessive disorder caused by a deficiency in peroxisome biogenesis (PEX gene mutations), leading to the accumulation of VLCFAs. * **Adrenoleukodystrophy (X-linked):** Defective transport of VLCFAs into peroxisomes, causing demyelination and adrenal insufficiency. * **Marker Enzyme:** Catalase is the gold-standard biochemical marker for identifying peroxisomes in cell biology.

Q: What is true about competitive inhibition?

Increases Km. ### Explanation In **Competitive Inhibition**, the inhibitor structurally resembles the substrate and competes for the same **active site** on the enzyme [1]. **1. Why the Correct Answer is Right (Increases Km):** * **Concept:** $K_m$ (Michaelis constant) represents the substrate concentration required to reach half of the maximum velocity ($V_{max}$). It is an inverse measure of the enzyme's affinity for its substrate [1]. * **Mechanism:** Because the inhibitor competes for the active site, more substrate is required to displace the inhibitor and achieve the same reaction rate. This effectively **lowers the affinity** of the enzyme for the substrate, leading to an **increase in $K_m$** [1]. **2. Why the Incorrect Options are Wrong:** * **Options A & C (Vmax):** In competitive inhibition, **$V_{max}$ remains unchanged**. If the substrate concentration is increased to a sufficiently high level, it will eventually outcompete the inhibitor, allowing the enzyme to reach its maximum potential velocity [1]. * **Option D (Decreases Km):** A decrease in $K_m$ would imply an increase in affinity, which does not occur in any standard form of inhibition. **3. High-Yield Clinical Pearls for NEET-PG:** * **Lineweaver-Burk Plot:** On a double-reciprocal plot, competitive inhibition shows lines that **intersect on the Y-axis** (same $V_{max}$) but have different X-intercepts (increased $K_m$) [1]. * **Classic Clinical Examples:** * **Statins** (e.g., Atorvastatin) compete with HMG-CoA for HMG-CoA reductase. * **Methanol poisoning** is treated with **Ethanol** (competitive inhibition of Alcohol Dehydrogenase). * **Methotrexate** competes with dihydrofolate for Dihydrofolate Reductase. * **Sulfonamides** compete with PABA in bacterial folic acid synthesis.

Q: Elevated levels of serum glutamic oxaloacetic transaminase is indicative of what condition?

Liver disease. **Explanation:** **Serum Glutamic Oxaloacetic Transaminase (SGOT)**, also known as **Aspartate Aminotransferase (AST)**, is a pyridoxal phosphate (PLP)-dependent enzyme found primarily in the liver, heart, skeletal muscle, and kidneys. Under normal physiological conditions, SGOT remains intracellular. However, when there is damage to the hepatocytes (liver cells), the cell membrane integrity is compromised, causing the enzyme to leak into the bloodstream. Therefore, elevated serum levels serve as a sensitive biochemical marker for **liver disease**, such as viral hepatitis, alcoholic cirrhosis, or toxic liver injury. **Analysis of Options:** * **Option A & B:** SGOT is an enzyme that catalyzes the reversible transfer of an amino group between aspartate and alpha-ketoglutarate to form **glutamic acid** and **oxaloacetic acid**. Its elevation in the serum indicates cellular damage/leakage, not a nutritional deficiency of its substrates or products. * **Option C (Correct):** As explained, elevated SGOT is a hallmark of hepatocellular injury. **High-Yield Clinical Pearls for NEET-PG:** * **AST vs. ALT:** While SGOT (AST) is found in multiple organs, **SGPT (ALT)** is more specific to the liver. * **De Ritis Ratio (AST/ALT):** * A ratio **> 2:1** is highly suggestive of **Alcoholic Liver Disease**. * A ratio **< 1** is typically seen in **Viral Hepatitis**. * **Myocardial Infarction (MI):** Historically, SGOT was used as a cardiac marker as it rises 6–8 hours after an MI, though it has been replaced by more specific markers like Troponin T/I. * **Co-enzyme:** Remember that all transaminases require **Vitamin B6 (Pyridoxine)** as a cofactor.

Q: Which of the following is a marker for biliary tract obstruction?

Alkaline phosphatase. **Explanation:** **Alkaline Phosphatase (ALP)** is the correct answer because it is a classic marker of **cholestasis** (biliary tract obstruction). ALP is an enzyme found on the canalicular membranes of hepatocytes and the epithelial cells lining the bile ducts. When bile flow is obstructed (due to gallstones, tumors, or strictures), the increased pressure and the detergent action of accumulated bile salts cause the induction and release of ALP into the bloodstream. **Analysis of Incorrect Options:** * **Alanine Transaminase (ALT) & Aspartate Transaminase (AST):** These are markers of **hepatocellular injury**. While they may be mildly elevated in biliary obstruction, their primary diagnostic value lies in detecting damage to the liver parenchyma (e.g., viral hepatitis or drug-induced liver injury). ALT is more specific to the liver than AST. * **Creatinine Kinase (CK):** This is a marker for **muscle damage** (skeletal or cardiac). It has no diagnostic relevance to the biliary system or liver function. **High-Yield Clinical Pearls for NEET-PG:** * **Gamma-Glutamyl Transferase (GGT):** This is the most sensitive marker for biliary obstruction and is used to confirm that an elevated ALP is of hepatic origin (rather than bone). * **Pattern Recognition:** A disproportionate rise in ALP compared to ALT/AST suggests an **obstructive (cholestatic) pattern**, whereas a disproportionate rise in ALT/AST suggests a **hepatocellular pattern**. * **Other ALP Sources:** Remember that ALP is also found in **bone** (osteoblastic activity), the **placenta** (Regan isoenzyme), and the **intestine**. Always check GGT to differentiate.

Q: Which of the following is the cofactor for dopamine hydroxylase?

Cu. **Explanation:** The correct answer is **D. Cu (Copper)**. **Dopamine Beta-Hydroxylase (DBH)** is the enzyme responsible for converting Dopamine into Norepinephrine within the catecholamine synthesis pathway. This enzyme is a copper-containing oxygenase located primarily in the synaptic vesicles of postganglionic sympathetic neurons and the adrenal medulla. It requires **Copper (Cu²⁺)** as a specific metal cofactor and **Vitamin C (Ascorbic acid)** as a reducing agent to function. During the reaction, copper undergoes cyclic oxidation and reduction to facilitate the hydroxylation of the substrate. **Why other options are incorrect:** * **A. Fe (Iron):** Iron is a cofactor for **Tyrosine Hydroxylase** (the rate-limiting step of catecholamine synthesis) and Phenylalanine Hydroxylase, but not for Dopamine Hydroxylase. * **B. Mg (Magnesium):** Magnesium is typically a cofactor for enzymes involving ATP transfer, such as kinases (e.g., Hexokinase) or **COMT** (Catechol-O-methyltransferase) in catecholamine degradation. * **C. Mn (Manganese):** Manganese is a cofactor for enzymes like Pyruvate Carboxylase and Arginase in the urea cycle. **High-Yield Clinical Pearls for NEET-PG:** * **Vitamin C Connection:** Vitamin C deficiency (Scurvy) can lead to impaired norepinephrine synthesis because it is the essential co-substrate for Dopamine Beta-Hydroxylase. * **Menkes Disease:** This is an X-linked recessive disorder of copper absorption. Low copper levels lead to decreased activity of copper-dependent enzymes, including DBH (causing neurological issues) and Lysyl Oxidase (causing connective tissue defects/kinky hair). * **Rate-Limiting Step:** Remember that Tyrosine Hydroxylase is the rate-limiting step in catecholamine synthesis, while DBH is the only enzyme in the pathway located inside vesicles.

Question 1

Trypsin cleaves which of the following amino acids?

Accepted Answer

Lysine

Answer

Arginine

Answer

Glutamate

Answer

Proline

Question 2

The type of enzyme inhibition observed when xanthine oxidase is inhibited by allopurinol is an example of:

Accepted Answer

Suicidal

Answer

Noncompetitive

Answer

Uncompetitive

Answer

Allosteric

Question 3

Enzyme levels in tissue injury are due to which of the following mechanisms?

Accepted Answer

Lysis of cells

Answer

Enzyme secretion

Answer

Absence of inhibitors in serum

Answer

All of the above

Question 4

What is true about Glutathione reductase?

Accepted Answer

It is a free radical scavenger.

Answer

It is a sulfur-containing enzyme.

Answer

It is important in methemoglobinemia.

Answer

All of the above.

Question 5

Sulfite oxidase is the last enzyme in the pathway for degradation of sulfur-containing amino acids. What is the cofactor for sulfite oxidase?

Accepted Answer

Molybdenum

Answer

Copper (Cu)

Answer

Zinc (Zn)

Answer

Iron (Fe)

Question 6

Which organelle is primarily responsible for the catabolism of hydrogen peroxide (H2O2)?

Accepted Answer

Peroxisomes

Answer

Mitochondria

Answer

Endoplasmic reticulum

Answer

Lysosomes

Question 7

What is true about competitive inhibition?

Accepted Answer

Increases Km

Answer

Increases Vmax

Answer

Decreases Vmax

Answer

Decreases Km

Question 8

Elevated levels of serum glutamic oxaloacetic transaminase is indicative of what condition?

Accepted Answer

Liver disease

Answer

Deficiency of glutamic acid

Answer

Deficiency of oxaloacetic acid

Answer

All of the above

Question 9

Which of the following is a marker for biliary tract obstruction?

Accepted Answer

Alkaline phosphatase

Answer

Aspartate transaminase

Answer

Alanine transaminase

Answer

Creatinine kinase

Question 10

Which of the following is the cofactor for dopamine hydroxylase?

Accepted Answer

Cu

Answer

Fe

Answer

Mg

Answer

Mn

Enzymes — MCQs

Enzymes — MCQs

On this page

Practice by Chapter

Want unlimited practice?